EX-15.1 3 exhibit15-1.htm EXHIBIT 15.1 Trillium Therapeutics Inc.: Exhibit 15.1 - Filed by newsfilecorp.com

Consent of Independent Registered Public Accounting Firm

We consent to the reference to our firm under the caption “Statement by Experts” and to the use of our reports dated March 27, 2014 and April 29, 2013 with respect to the financial statements of Trillium Therapeutics Inc. (formerly Stem Cell Therapeutics Corp.) in the Registration Statement on Form 20-F (Amendment No. 2) for the registration of common shares of Trillium Therapeutics Inc.

  /s/ Ernst & Young LLP
Toronto, Canada Chartered Professional Accountants
November 26, 2014 Licensed Public Accountants